Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

303.69
Delayed Data
As of Aug 28
 -0.80 / -0.26%
Today’s Change
265.00
Today|||52-Week Range
480.18
-10.53%
Year-to-Date

Today’s Trading

Previous close304.49
Today’s open301.00
Day’s range299.76 - 306.45
Volume2,059,085
Average volume (3 months)2,342,154
Market cap$71.6B
Dividend yield--
Data as of 4:14pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+58.39%
Earnings growth (this year)+15.12%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+39.61%
P/E ratio20.6
Price/Sales8.30
Price/Book6.61

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+0.17+0.11%
BXLTBaxalta Inc-1.18-3.24%
BAXBaxter International...+0.16+0.41%
XONIntrexon Corp+1.93+4.31%
Data as of 4:04pm ET, 08/28/2015

Financials

Next reporting dateOctober 27, 2015
EPS forecast (this quarter)$3.92
Annual revenue (last year)$9.7B
Annual profit (last year)$2.9B
Net profit margin30.27%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
George A. Scangos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers